Cyclosporine Resolved Late Graft Failure After Autologous Transplantation for Neuroblastoma by Promoting CD4 T‐Cell Recovery

Key Points

• This research investigates how cyclosporine affects graft failure and CD4 T-cell recovery following autologous transplantation in neuroblastoma cases.
• Analyzed the effects of cyclosporine on graft outcomes after transplantation
• Evaluated CD4 T-cell levels post-treatment
• Utilized clinical metrics to assess graft success
• Cyclosporine significantly reduced the incidence of late graft failure
• Patients showed improved recovery of CD4 T-cells after treatment with cyclosporine
• Overall graft success rates increased in those receiving cyclosporine compared to those who did not